365 related articles for article (PubMed ID: 34638365)
1. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation.
Pelizzaro F; Gambato M; Gringeri E; Vitale A; Cillo U; Farinati F; Burra P; Russo FP
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638365
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
Jiang J; Huang H; Chen R; Lin Y; Ling Q
Front Immunol; 2023; 14():1092401. PubMed ID: 36875077
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
[TBL] [Abstract][Full Text] [Related]
4. The management of post-transplantation recurrence of hepatocellular carcinoma.
Rajendran L; Ivanics T; Claasen MP; Muaddi H; Sapisochin G
Clin Mol Hepatol; 2022 Jan; 28(1):1-16. PubMed ID: 34610652
[TBL] [Abstract][Full Text] [Related]
5. Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?
Angelico R; Parente A; Manzia TM
Transl Gastroenterol Hepatol; 2017; 2():74. PubMed ID: 29034347
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues.
Marrone G; Leone MS; Biolato M; Liguori A; Bianco G; Spoletini G; Gasbarrini A; Miele L; Pompili M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067299
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.
Sposito C; Citterio D; Virdis M; Battiston C; Droz Dit Busset M; Flores M; Mazzaferro V
World J Gastroenterol; 2022 Sep; 28(34):4929-4942. PubMed ID: 36160651
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors in liver transplant: a case series.
Rudolph M; Shah SA; Quillin R; Lemon K; Olowokure O; Latif T; Sohal D
J Gastrointest Oncol; 2023 Apr; 14(2):1141-1148. PubMed ID: 37201081
[TBL] [Abstract][Full Text] [Related]
10. Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation.
Guerrini GP; Berretta M; Tarantino G; Magistri P; Pecchi A; Ballarin R; Di Benedetto F
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3421-3435. PubMed ID: 28829499
[TBL] [Abstract][Full Text] [Related]
11. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.
Rahimi RS; Trotter JF
Ann Gastroenterol; 2015; 28(3):323-330. PubMed ID: 26130250
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference.
Berenguer M; Burra P; Ghobrial M; Hibi T; Metselaar H; Sapisochin G; Bhoori S; Kwan Man N; Mas V; Ohira M; Sangro B; van der Laan LJW
Transplantation; 2020 Jun; 104(6):1143-1149. PubMed ID: 32217940
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?
Lerut J; Iesari S; Foguenne M; Lai Q
Transl Gastroenterol Hepatol; 2017; 2():80. PubMed ID: 29167827
[TBL] [Abstract][Full Text] [Related]
16. Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients.
Zucker KM; Gomez PA; Kezirian O; Mehta S
Gastroenterology Res; 2021 Jun; 14(3):190-193. PubMed ID: 34267835
[TBL] [Abstract][Full Text] [Related]
17. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
Sposito C; Cucchetti A; Mazzaferro V
Dig Dis Sci; 2019 Apr; 64(4):1001-1007. PubMed ID: 30852770
[TBL] [Abstract][Full Text] [Related]
18. Imaging of hepatocellular carcinoma recurrence after liver transplantation.
Mamone G; Caruso S; Milazzo M; Porrello G; Di Piazza A; Gentile G; Carollo V; Crinò F; Marrone G; Sparacia G; Maruzzelli L; Miraglia R; Gruttadauria S
Insights Imaging; 2023 May; 14(1):84. PubMed ID: 37184688
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma.
Ismail MS; Hassan M; Khaderi SA; Yousry WA; Kamal El-Din MM; Bahaa El-Din MM; El Sayed OA; Kaseb AO; Goss JA; Kanwal F; Jalal PK
World J Hepatol; 2020 Sep; 12(9):628-640. PubMed ID: 33033569
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.
Luo Y; Teng F; Fu H; Ding GS
World J Gastrointest Oncol; 2022 Jan; 14(1):163-180. PubMed ID: 35116109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
